	1
Drug Development and Industrial Pharmacy	Drug Development and Industrial Pharmacy, 1, 25% Drug Development and Industrial Pharmacy 1 publication, 25%
Russian Chemical Reviews	Russian Chemical Reviews, 1, 25% Russian Chemical Reviews 1 publication, 25%
Nanomedicine: Nanotechnology, Biology, and Medicine	Nanomedicine: Nanotechnology, Biology, and Medicine, 1, 25% Nanomedicine: Nanotechnology, Biology, and Medicine 1 publication, 25%
Materials Today Chemistry	Materials Today Chemistry, 1, 25% Materials Today Chemistry 1 publication, 25%
	1

Publishers

	1 2
Elsevier	Elsevier, 2, 50% Elsevier 2 publications, 50%
Taylor & Francis	Taylor & Francis, 1, 25% Taylor & Francis 1 publication, 25%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii	Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii, 1, 25% Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii 1 publication, 25%
	1 2

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

PDF

Metrics

Cite this

GOST |

Cite this

GOST Copy

Ali A. et al. Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect // International Journal of Nanomedicine. 2023. Vol. Volume 18. pp. 7417-7440.

GOST all authors (up to 50) Copy

Ali A., Abdelmohymen A., Mostafa N., Magdy G., Mazyed E. Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect // International Journal of Nanomedicine. 2023. Vol. Volume 18. pp. 7417-7440.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.2147/ijn.s434840

UR - https://doi.org/10.2147/ijn.s434840

TI - Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect

T2 - International Journal of Nanomedicine

AU - Ali, Abdelwahab

AU - Abdelmohymen, Alshimaa

AU - Mostafa, Nada

AU - Magdy, Galal

AU - Mazyed, Eman

PY - 2023

DA - 2023/12/07

PB - Taylor & Francis

SP - 7417-7440

VL - Volume 18

PMID - 38090365

SN - 1176-9114

SN - 1178-2013

ER -

BibTex

Cite this

BibTex (up to 50 authors) Copy

@article{2023_Ali,

author = {Abdelwahab Ali and Alshimaa Abdelmohymen and Nada Mostafa and Galal Magdy and Eman Mazyed},

title = {Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect},

journal = {International Journal of Nanomedicine},

year = {2023},

volume = {Volume 18},

publisher = {Taylor & Francis},

month = {dec},

url = {https://doi.org/10.2147/ijn.s434840},

pages = {7417--7440},

doi = {10.2147/ijn.s434840}

}

Publisher

Taylor & Francis

Journal

International Journal of Nanomedicine

scimago Q1

wos Q1

SJR

1.306

CiteScore

10.9

Impact factor

6.5

ISSN

11769114 (Print)

11782013 (Electronic)